The global osteoporosis drugs market was
valued at $8,835.4 million in 2015 and
it is expected to grow at a CAGR of 3.8% during 2016-2022. Among
the various classes of osteoporosis drugs, the rank ligand inhibitor segment is
expected to witness the fastest growth, a CAGR of 4.3% during the forecast
period.
The
global osteoporosis
drugs market is growing at a significant rate due to growing
geriatric population, increasing awareness of osteoporosis and increasing
healthcare expenditure. The increasing prevalence of osteoporosis in
postmenopausal women and the increasing focus on research & development of
new drugs for treatment of osteoporosis are also driving the growth of the
global osteoporosis drugs market.
Explore Report with Detailed TOC at: https://www.psmarketresearch.com/market-analysis/osteoporosis-drugs-market
Osteoporosis disease is
the most common bone disease, which occurs due to reduced bone
mineral density and causes increased risk of fractures and fragile bones. It
leads to abnormally porous bones such as sponge, which facilitate the weakening
of bones and painful fracture. Most of the spine, hip, shoulder and
forearm fractures occur within aged people of 65 years and above.
Some of the signs and
symptoms of the osteoporosis are falling risk and fractures. Diagnostic tests
of osteoporosis include X-Ray test and traditional radiography tests, which is further
confirmed by bone density test. Osteoporosis disease can be managed by
nutrition emphasis, lifestyle management and medicines.
The factors such as strict
regulatory requirement for the approval of osteoporosis drugs, patent expiry of
blockbuster drugs, and side-effects and complications associated with
osteoporosis drugs are inhibiting
the growth of the global market.
Browse Related Research: https://www.psmarketresearch.com/industry-report/healthcare
Geographically, North America dominated the
global market of osteoporosis drugs in 2015; whereas the Asia-Pacific market is
expected to witness the fastest growth, a CAGR of 4.2% during the forecast
period. This is due to the growing geriatric population, increasing awareness
of osteoporosis drugs and increasing healthcare expenditure in the region.
Some of the key companies operating
in the global osteoporosis drugs market include Eli Lilly and Company, Pfizer
Inc., F. Hoffmann-La Roche, Novartis International AG, Merck & Co. Inc. and
Amgen Inc.
About P&S Market Research
P&S Market Research is a market
research company, which offers market research and consulting services for
various geographies around the globe. We provide market research reports,
industry forecasting reports, business intelligence, and research based
consulting services across different industry/business verticals.
As one of the top growing market research
agency, we’re keen upon providing market landscape and accurate forecasting.
Our analysts and consultants are proficient with business intelligence and
market analysis, through their interaction with leading companies of the
concerned domain. We help our clients with B2B market research and assist them
in identifying various windows of opportunity, and framing informed and
customized business expansion strategies in different regions.
Contact:
Deep
Deep
Assistant – Client Partner
347, 5th Ave. #1402
New York City, NY - 10016
Toll-Free: +1-888-778-7886 (USA/Canada)
Email: enquiry@psmarketresearch.comWeb: https://www.psmarketresearch.com
